Perampanel (Fycompa®)

Assessment Status Rapid Review Complete
Drug Perampanel
Brand Fycompa®
Indication For treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.
Assessment Process
Rapid review commissioned 12/07/2013
Rapid review completed 26/07/2013
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended